HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

477.614

-14.602-2.97%

Number of Gainers:9

Number of Losers:40

Number of Flat:2

PE:- -

High:492.483

Open:492.216

Low:476.477

Close:492.216

Volume:448.98M

Turnover:13.45B

Market Cap:3.01T

Float Cap:2.11T

Loading ...

Medical Equipment Procurement Shows Sustained Monthly Recovery, Sector Valuations Poised for Rebound

Spero Q2 FY26 Net Loss Widens to $9.6 Million; Revenue Posts no Revenue

Microport Scientific Sees 12%-14% Y/Y Revenue Growth in Continuing Operations for HY

LifeTech Expects H1 Net Loss Attributable to Owners of RMB 30 Million-RMB 40 Million vs Year-Ago Profit

J.P. Morgan Asset Management: U.S. 'Teflon Inflation' Fails to Stick, Fed Rate Hikes Unnecessary

MICROPORT Issues Profit Warning, Expects Net Loss for First Half

Microport Scientific - Sees 12%-14% Y/Y Revenue Growth in Cont Ops for Hy

THOMSON REUTERS

Microport Scientific - Expects Net Loss from Cont Ops of not More than $50 Mln for Six Months Ended 30 June 2026

THOMSON REUTERS

LIFETECH SCI Issues Profit Warning, Expects H1 Net Loss of 30-40 Million Yuan

LifeTech Scientific - Expects Net Profit Attributable to Owners of Rmb110 Mln–RMB120 Mln for Six Months Ended June 2026

THOMSON REUTERS

LifeTech Scientific Sees Decrease in Hy Revenue

THOMSON REUTERS

LIFETECH SCI Appoints Fang Yu as Authorized Representative

China Tower (SEHK:788) Stock Looks Cheap as Revenue Questions Persist

Simply Wall St.

LifeTech Scientific Schedules Board Meeting to Review Interim Results

Modern Dental Group Files HKEX Next-Day Disclosure on Share Repurchase Cancellation

Yun Qu Yi Gains Full Access to JD Zhi Yi, Empowering a Million Grassroots Doctors at No Cost

Zhaoke Ophthalmology Signs Exclusive Distribution Deal with Pharmentum Biopharma for Epinastine Eye Drops in China

Zhaoke Ophthalmology - Enters Exclusive Distribution Agreement with Pharmentum Biopharma in China

THOMSON REUTERS

Zhaoke Ophthalmology - Agreement to Commercialize Epinastine Hydrochloride Eye Drops in China (Excluding Hong Kong, Macau and Taiwan)

THOMSON REUTERS

Hygeia Healthcare Schedules Board Meeting to Review Interim Results, Weigh Dividend Recommendation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK1583/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"Hillhouse Capital Related","latestPrice":477.61407,"timestamp":1787558899038,"preClose":492.21594,"halted":0,"volume":448977889,"delay":0,"changeRate":-0.029666,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-14.601868,"latestTime":"08-24 16:00:00","open":492.21594,"high":492.48306,"low":476.4772,"amount":13451380024.5,"amplitude":0.032518,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"pbRate":2.251969,"peRate":52.53658,"turnoverRate":0.004085,"increases":6,"decrements":42,"flats":3,"marketCap":3006262293376,"floatMarketCap":2108846506848},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":492.48306,"amplitude":0.032518,"preClose":492.21594,"low":476.4772,"pbRate":"2.251969","latestPrice":477.61407,"volume":448977889,"delay":0,"open":492.21594,"prevYearClose":503.90085,"prevWeekClose":492.216,"prevMonthClose":470.497,"prevQuarterClose":402.118,"fiveDayClose":483.304,"twentyDayClose":465.583,"sixtyDayClose":424.514,"secType":"PLATE","market":"HK","turnoverRate":0.004085,"peRate":52.53658,"marketCap":3006262293376,"floatMarketCap":2108846506848,"timestamp":1787558899038,"nameCN":"Hillhouse Capital Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":9,"down":40,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1128373791","title":"Medical Equipment Procurement Shows Sustained Monthly Recovery, Sector Valuations Poised for Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1128373791","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128373791?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:18","pubTimestamp":1786576706,"startTime":"0","endTime":"0","summary":"GTHT has released a research report noting that the ongoing implementation of equipment renewal policies is expected to drive long-term increases in medical equipment procurement levels. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","AGNG","601211","GDOC","MDEV","LGHT","CZA","REVS","BK0184","BK1574","BK0012","RSPH","09996","LCO","BK0201","BK0183","159883","IEIH","HART","NIFE","BK1100","BK1147","MEDX","BK0276","LNGR","02611","PTH","BK1564","BK0028","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659547907","title":"Spero Q2 FY26 Net Loss Widens to $9.6 Million; Revenue Posts no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2659547907","media":"Reuters","labels":["executive","corporation","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659547907?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:01","pubTimestamp":1786564908,"startTime":"0","endTime":"0","summary":"Spero Q2 FY26 net loss widens to $9.6 million; revenue posts no revenueSpero Therapeutics posted a Q2 net loss of $9.6 million, widening from a $1.7 million loss a year earlier; loss per share widened","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL5QhQXl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,corporation,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1188198961.HKD","LU1969619763.USD","LU2097828805.USD","LU2210150020.SGD","LU0244354667.USD","BK4588","01801","BK4139","LU2488822045.USD","LU2097828631.EUR","BK1589","LU2210149790.SGD","IE00BN0W2T93.GBP","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SPRO","IE00BGHQF748.EUR","LU2097828557.USD","LU2242644610.SGD","HK0000165453.HKD","LU2328871848.SGD","SG9999014013.SGD","LU0463099449.HKD","LU2097828474.EUR","SG9999014005.SGD","BK4112","LU0502904849.HKD","BK4585","LU0314104364.USD","IE00BN0W2V16.EUR","LU0326950275.SGD","LU0455707207.USD","LU2095319765.USD","BK1161","IE00BN0W2W23.USD","SG9999014039.USD","LU2097828714.EUR","IE00BKPKM429.USD","BCDF","BK1583","SG9999014021.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658590674","title":"Microport Scientific Sees 12%-14% Y/Y Revenue Growth in Continuing Operations for HY","url":"https://stock-news.laohu8.com/highlight/detail?id=2658590674","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658590674?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:37","pubTimestamp":1786549060,"startTime":"0","endTime":"0","summary":"Aug 12 (Reuters) - Microport Scientific Corp <0853.HK>::*SEES 12%-14% Y/Y REVENUE GROWTH IN CONTINUING OPERATIONS FOR HY*EXPECTS NET LOSS FROM CONTINUING OPERATIONS OF NOT MORE THAN $50 MILLION FOR SI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nRSDbqxts:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1583","00853","BK1100","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658906338","title":"LifeTech Expects H1 Net Loss Attributable to Owners of RMB 30 Million-RMB 40 Million vs Year-Ago Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2658906338","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658906338?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:14","pubTimestamp":1786547645,"startTime":"0","endTime":"0","summary":"LifeTech expects H1 net loss attributable to owners of RMB 30 million-RMB 40 million vs year-ago profitLifeTech flagged a sharp earnings drop for the six months ended June 30, 2026, based on unaudited","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL3D39X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1600","BK1100","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133577864","title":"J.P. Morgan Asset Management: U.S. 'Teflon Inflation' Fails to Stick, Fed Rate Hikes Unnecessary","url":"https://stock-news.laohu8.com/highlight/detail?id=1133577864","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133577864?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:05","pubTimestamp":1786547138,"startTime":"0","endTime":"0","summary":"David Kelly, Chief Global Strategist at J.P. Morgan Asset Management, stated that the Federal Reserve should maintain its current interest rate policy. He expects inflation to gradually decline as...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLF","UPRO","MUNX","HIBL","HK0000934320.USD","FLGV","SMAX","ESmain","UBmain","BK1258","IVV","NGHT","UUP","VGIT","OEX","SGOV","BBSB","SHV","BK4559","TFJL","US3Y.BOND","EDV","US7Y.BOND","SPXU","GOVT","RMIF","TMF","BK4534","OOQB","CWS","TBT","TLH","DMAX","SPYB","SPYM","SPYQ","BBLB","DPST","SPUU","AGG","MESmain","BK4588","VCIT","BSV","HMOP","BK4561","LQD","BK4504","WAMA","EBUF","BK4581","CRXP","BK1583","SH","LIAJ","TLTX","BWX","RULE","TPLS","OEF","09983","CIVG","NEMD","SHY","NELS","PBDC","TLTW","SPYU","ZFmain","KRE","TLTI","BK4550","US12M.BOND","SKRE","BK4585","ZBmain","FAZ","IEF","MUB","FEM","XBIL","JPST","SPXS","TSYW","UDN","GABF","IEI","HYG","GBIL","UNIY","US2Y.BOND","IGOV","SPDN","SSO","IAT","SPYI","TBIL","MMAX","VCSH","MYCN","AMGR","FLXI",".SPX","US10Y.BOND","YSPY","VEXC","SCHO","TNmain","MINT","EMPB","RAUS","EDGF","US6M.BOND","ADVX","US30Y.BOND","DBND","BK4535","PFI","SDS","BIL","VGSH","USHY","XLRI","SPXL","FITZ","BOXX","TBJL","VOO","GOLY","KRX","BSR","ZTmain","US5Y.BOND","TLT","BWZ","VFH","BK1542","KBWB","UBT","TYO","BK1229","KBE","ISHG","SPY","TIP","BBIB","ZROZ","BND","JULD","VGLT","BOND","TRUF","SPYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147212911","title":"MICROPORT Issues Profit Warning, Expects Net Loss for First Half","url":"https://stock-news.laohu8.com/highlight/detail?id=1147212911","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147212911?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:30","pubTimestamp":1786545031,"startTime":"0","endTime":"0","summary":"MICROPORT (00853) has issued a profit warning, announcing that for the six months ending June 30, 2026, the group's revenue from continuing operations is expected to grow by approximately 12% to 14%...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","BK1585","00853","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903403","title":"Microport Scientific - Sees 12%-14% Y/Y Revenue Growth in Cont Ops for Hy","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903403","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903403?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:17","pubTimestamp":1786544253,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1585","BK1583","00853","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658034089","title":"Microport Scientific - Expects Net Loss from Cont Ops of not More than $50 Mln for Six Months Ended 30 June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658034089","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658034089?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:17","pubTimestamp":1786544253,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491C8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","00853","BK1585","BK1100","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100565577","title":"LIFETECH SCI Issues Profit Warning, Expects H1 Net Loss of 30-40 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1100565577","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100565577?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:24","pubTimestamp":1786541079,"startTime":"0","endTime":"0","summary":"The company known as LIFETECH SCI (01302) has issued a profit warning to the stock exchange. Excluding several non-recurring items, the group anticipates a net profit attributable to equity holders...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","01302","BK1583","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658489970","title":"LifeTech Scientific - Expects Net Profit Attributable to Owners of Rmb110 Mln–RMB120 Mln for Six Months Ended June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2658489970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658489970?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:09","pubTimestamp":1786540168,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44916O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1583","BK1600","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658197048","title":"LifeTech Scientific Sees Decrease in Hy Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2658197048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658197048?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:09","pubTimestamp":1786540168,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN44916O:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01302","BK1100","BK1583","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180979499","title":"LIFETECH SCI Appoints Fang Yu as Authorized Representative","url":"https://stock-news.laohu8.com/highlight/detail?id=1180979499","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180979499?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:00","pubTimestamp":1786539615,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) announced that Executive Director Mr. Fang Yu has been appointed as the company's authorized representative under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, effective from August 12, 2026.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","BK1600","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972223","title":"China Tower (SEHK:788) Stock Looks Cheap as Revenue Questions Persist","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972223","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972223?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:35","pubTimestamp":1786534540,"startTime":"0","endTime":"0","summary":"China Tower stock closed at HK$9.315 after a choppy few months that left the 90 day return down about 17%. The market came into this earnings print with low expectations. The headline is that profits are doing the heavy lifting. Quarterly net income reached about C¥3.5b and trailing earnings per share now sit around C¥0.76, which supports a P/E of 10.5x, well below Asian telecom peers. The immediate price reaction tells only a small part of the story. The bigger question is how long this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9022000-choice2-main-header/1585186701264"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/telecom/hkg-788/china-tower-shares/news/china-tower-sehk788-stock-looks-cheap-as-revenue-questions-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/telecom/hkg-788/china-tower-shares/news/china-tower-sehk788-stock-looks-cheap-as-revenue-questions-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1521","00788","BK1133","LU0823413587.USD","BK1506","BK1529","IE00BG0RBZ43.SGD","IE00BHRH8C09.USD","BK1589","BK1583","IE00BHRH8D16.HKD","LU0823413660.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658597495","title":"LifeTech Scientific Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658597495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658597495?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:34","pubTimestamp":1786534463,"startTime":"0","endTime":"0","summary":"LifeTech Scientific schedules board meeting to review interim resultsLifeTech Scientific will hold a board meeting on Aug. 28, 2026 to review unaudited interim results for the six months ended June 30","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLhTjrd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","BK1600","01302"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658497433","title":"Modern Dental Group Files HKEX Next-Day Disclosure on Share Repurchase Cancellation","url":"https://stock-news.laohu8.com/highlight/detail?id=2658497433","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658497433?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:25","pubTimestamp":1786533945,"startTime":"0","endTime":"0","summary":"Modern Dental Group files HKEX next-day disclosure on share repurchase cancellationModern Dental canceled 636,000 shares repurchased between June 3 and June 30, per its next-day disclosure return.Issu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbbsXnH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","BK1593","03600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149062959","title":"Yun Qu Yi Gains Full Access to JD Zhi Yi, Empowering a Million Grassroots Doctors at No Cost","url":"https://stock-news.laohu8.com/highlight/detail?id=1149062959","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149062959?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:01","pubTimestamp":1786528893,"startTime":"0","endTime":"0","summary":"JD Health and Yun Qu Yi have officially entered into a strategic partnership leveraging the \"AI plus supply chain\" strengths of JD Health and Yun Qu Yi's extensive network of community-level...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000320223.HKD","BK4505","BK4585","BK4524","BK4220","BK1142","BK4614","LU1188198961.HKD","SG9999002463.SGD","BK1583","JD","SGXZ86797644.SGD","LU0307460666.USD","LU0051755006.USD","HK0000306701.USD","BK4509","IE00BGV7N243.SGD","HK0000306685.HKD","86618","BK1591","IE0008368742.USD","BK4558","LU0463099449.HKD","BK4588","BK1571","BK1247","LU1688375341.USD","BK4122","LU0588546209.SGD","BK4531","HK0000320264.USD","KJD","BK4526","BK4504","BK1615","BK4503","BK1515","BK4551","BK4579","09618","BK1589","LU0106959298.USD","LU0326950275.SGD","LU0456827905.SGD","SGXZ62798434.SGD","LU0244354667.USD","LU1880383366.USD","06618"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978528","title":"Zhaoke Ophthalmology Signs Exclusive Distribution Deal with Pharmentum Biopharma for Epinastine Eye Drops in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978528","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658978528?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:55","pubTimestamp":1786524908,"startTime":"0","endTime":"0","summary":"Zhaoke Ophthalmology signs exclusive distribution deal with Pharmentum Biopharma for epinastine eye drops in ChinaZhaoke Ophthalmology entered a five-year exclusive distribution and promotion deal wit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL4MYV5S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1587","BK1574","BK1583","06622"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658978534","title":"Zhaoke Ophthalmology - Enters Exclusive Distribution Agreement with Pharmentum Biopharma in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2658978534","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658978534?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:54","pubTimestamp":1786524877,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490PQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06622","BK1191","BK1583","BK1574","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658785379","title":"Zhaoke Ophthalmology - Agreement to Commercialize Epinastine Hydrochloride Eye Drops in China (Excluding Hong Kong, Macau and Taiwan)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658785379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658785379?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:54","pubTimestamp":1786524877,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490PQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","06622","BK1574","BK1587","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658192009","title":"Hygeia Healthcare Schedules Board Meeting to Review Interim Results, Weigh Dividend Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2658192009","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658192009?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:46","pubTimestamp":1786524419,"startTime":"0","endTime":"0","summary":"Hygeia Healthcare schedules board meeting to review interim results, weigh dividend recommendationHygeia Healthcare will hold a board meeting on Aug. 27, 2026 to review interim results for the six mon","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL75npPb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK1209","LU0329678170.USD","LU0329678337.USD","06078","BK1583","LU0737861772.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":15,"totalSize":337,"code":"91000000","status":"200"}]}}